From the radiologic pathology archives: Adrenal tumors and tumor-like conditions in the adult: Radiologic-pathologic correlation

Radiographics

Volumn 34, Issue 3, 2014, Pages 805-829

  Lattin Jr , Grant E ^a,b   Sturgill, Eric D ^b,c   Tujo, Charles A ^a,d   Marko, Jamie ^a,e   Sanchez Maldonado, Katherine W ^f   Craig, William D ^a,b,g   Lack, Ernest E ^h  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b American Institute for Radiologic Pathology   (United States)

^c NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

^d DAVID GRANT MEDICAL CENTER   (United States)

^e WALTER REED ARMY MEDICAL CENTER   (United States)

^f GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g SUBURBAN HOSPITAL   (United States)

^h JOINT PATHOLOGY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; CORTICOSTEROID;

ADRENAL DISEASE; ADRENAL TUMOR; ADULT; BLEEDING; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; CYST; FEMALE; FEMINIZATION; HUMAN; HYPERALDOSTERONISM; HYPERPLASIA; INCIDENTAL FINDING; MALE; PATHOLOGY; RADIOGRAPHY; SECONDARY; SECRETION (PROCESS); VIRILISM;

ADRENAL CORTEX HORMONES; ADRENAL GLAND DISEASES; ADRENAL GLAND NEOPLASMS; ADULT; CATECHOLAMINES; CUSHING SYNDROME; CYSTS; FEMALE; FEMINIZATION; HEMORRHAGE; HUMANS; HYPERALDOSTERONISM; HYPERPLASIA; INCIDENTAL FINDINGS; MALE; TOMOGRAPHY, X-RAY COMPUTED; VIRILISM;

EID: 84900432626     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.343130127     Document Type: Article

References (106)

1. Blake MA, Cronin CG, Boland GW. Adrenal imaging. AJR Am J Roentgenol 2010;194(6):1450-1460.
2. Arnold DT, Reed JB, Burt K. Evaluation and management of the incidental adrenal mass. Proc (Bayl Univ Med Cent) 2003;16(1):7-12.
3. Terzolo M, Stigliano A, Chiodini I, et al. AME position statement on adrenal incidentaloma. Eur J Endocrinol 2011;164(6):851-870.
4. Berland LL, Silverman SG, Gore RM, et al. Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol 2010;7(10):754-773.
5. Cawood TJ, Hunt PJ, O'Shea D, Cole D, Soule S. Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink? Eur J Endocrinol 2009;161(4): 513-527.
6. Young WF. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf) 2007;66(5): 607-618.
7. Lack EE. Tumors of the adrenal glands and extraadrenal paraganglia. Series 4, fascicle 8. Washington, DC: American Registry of Pathology, 2007; 1-297.
8. Mayo-Smith WW, Boland GW, Noto RB, Lee MJ. State-of-the-art adrenal imaging. RadioGraphics 2001;21(4):995-1012.
9. Motta-Ramirez GA, Remer EM, Herts BR, Gill IS, Hamrahian AH. Comparison of CT findings in symptomatic and incidentally discovered pheochromocytomas. AJR Am J Roentgenol 2005;185 (3):684-688.
10. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B. Incidentally discovered adrenal masses. Endocr Rev 1995;16(4):460-484.
11. Lloyd RV, Tischler AS, Kimura N, McNicol AM, Young WF Jr. Tumours of the adrenal gland. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. World Health Organization classification of tumours: pathology and genetics of tumours of endocrine organs. Lyon, France: IARC Press, 2004; 137-147.
12. Abrams HL, Siegelman SS, Adams DF, et al. Computed tomography versus ultrasound of the adrenal gland: a prospective study. Radiology 1982;143(1): 121-128.
13. Johnson PT, Horton KM, Fishman EK. Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls. RadioGraphics 2009;29(5):1333-1351.
14. Lee MJ, Hahn PF, Papanicolaou N, et al. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 1991;179(2):415-418.
15. Johnson PT, Horton KM, Fishman EK. Adrenal imaging with multidetector CT: evidence-based protocol optimization and interpretative practice. RadioGraphics 2009;29(5):1319-1331.
16. Korobkin M, Brodeur FJ, Francis IR, Quint LE, Dunnick NR, Londy F. CT time-attenuation washout curves of adrenal adenomas and nonadenomas. AJR Am J Roentgenol 1998;170(3):747-752.
17. Korobkin M, Giordano TJ, Brodeur FJ, et al. Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 1996;200(3): 743-747.
18. Elsayes KM, Mukundan G, Narra VR, et al. Adrenal masses: MR imaging features with pathologic correlation. RadioGraphics 2004;24(suppl 1):S73-S86.
19. Patel J, Davenport MS, Cohan RH, Caoili EM. Can established CT attenuation and washout criteria for adrenal adenoma accurately exclude pheochromocytoma? AJR Am J Roentgenol 2013;201 (1):122-127.
20. Russell RP, Masi AT. The prevalence of adrenal cortical hyperplasia at autopsy and its association with hypertension. Ann Intern Med 1970;73(2): 195-205.
21. Dobbie JW. Adrenocortical nodular hyperplasia: the ageing adrenal. J Pathol 1969;99(1):1-18.
22. Lockhart ME, Smith JK, Kenney PJ. Imaging of adrenal masses. Eur J Radiol 2002;41(2):95-112.
23. Sohaib SA, Hanson JA, Newell-Price JD, et al. CT appearance of the adrenal glands in adrenocorticotrophic hormone-dependent Cushing's syndrome. AJR Am J Roentgenol 1999;172(4):997-1002.
24. Kawashima A, Sandler CM, Ernst RD, et al. Imaging of nontraumatic hemorrhage of the adrenal gland. RadioGraphics 1999;19(4):949-963.
25. Rana AI, Kenney PJ, Lockhart ME, et al. Adrenal gland hematomas in trauma patients. Radiology 2004;230(3):669-675.
26. Sevitt S. Post-traumatic adrenal apoplexy. J Clin Pathol 1955;8(3):185-194.
27. Burks DW, Mirvis SE, Shanmuganathan K. Acute adrenal injury after blunt abdominal trauma: CT findings. AJR Am J Roentgenol 1992;158(3): 503-507.
28. Xarli VP, Steele AA, Davis PJ, Buescher ES, Rios CN, Garcia-Bunuel R. Adrenal hemorrhage in the adult. Medicine (Baltimore) 1978;57(3):211-221.
29. Rosenberger LH, Smith PW, Sawyer RG, Hanks JB, Adams RB, Hedrick TL. Bilateral adrenal hemorrhage: the unrecognized cause of hemodynamic collapse associated with heparin-induced thrombocytopenia. Crit Care Med 2011;39(4):833-838.
30. Arnason JA, Graziano FM. Adrenal insufficiency in the antiphospholipid antibody syndrome. Semin Arthritis Rheum 1995;25(2):109-116.
31. Arlt W. The approach to the adult with newly diagnosed adrenal insufficiency. J Clin Endocrinol Metab 2009;94(4):1059-1067.
32. Carvounis E, Marinis A, Arkadopoulos N, Theodosopoulos T, Smyrniotis V. Vascular adrenal cysts: a brief review of the literature. Arch Pathol Lab Med 2006;130(11):1722-1724.
33. Incze JS, Lui PS, Merriam JC, Austen G, Widrich WC, Gerzof SG. Morphology and pathogenesis of adrenal cysts. Am J Pathol 1979;95(2):423-432.
34. Sanal HT, Kocaoglu M, Yildirim D, et al. Imaging features of benign adrenal cysts. Eur J Radiol 2006; 60(3):465-469.
35. Ricci Z, Chernyak V, Hsu K, et al. Adrenal cysts: natural history by long-term imaging follow-up. AJR Am J Roentgenol 2013;201(5):1009-1016.
36. Polat P, Kantarci M, Alper F, Suma S, Koruyucu MB, Okur A. Hydatid disease from head to toe. RadioGraphics 2003;23(2):475-494.
37. Otal P, Escourrou G, Mazerolles C, et al. Imaging features of uncommon adrenal masses with histopathologic correlation. RadioGraphics 1999;19 (3):569-581.
38. Wedmid A, Palese M. Diagnosis and treatment of the adrenal cyst. Curr Urol Rep 2010;11(1):44-50.
39. Grumbach MM, Biller BM, Braunstein GD, et al. Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med 2003; 138(5):424-429.
40. Olsson CA, Krane RJ, Klugo RC, Selikowitz SM. Adrenal myelolipoma. Surgery 1973;73(5): 665-670.
41. Kenney PJ, Wagner BJ, Rao P, Heffess CS. Myelolipoma: CT and pathologic features. Radiology 1998;208(1):87-95.
42. Ioannidis O, Papaemmanouil S, Chatzopoulos S, et al. Giant bilateral symptomatic adrenal myelolipomas associated with congenital adrenal hyperplasia. Pathol Oncol Res 2011;17(3):775-778.
43. Kudva YC, Young WF Jr, Thompson GB, Grant CS, van Heerden JA. Adrenal incidentaloma: an important component of the clinical presentation spectrum of benign sporadic adrenal pheochromocytoma. Endocrinologist 1999;9(2):77-80.
44. Linnoila RI, Keiser HR, Steinberg SM, Lack EE. Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. Hum Pathol 1990;21(11):1168-1180.
45. Dluhy RG. Pheochromocytoma: death of an axiom. N Engl J Med 2002;346(19):1486-1488.
46. Nakamura E, Kaelin WG Jr. Recent insights into the molecular pathogenesis of pheochromocytoma and paraganglioma. Endocr Pathol 2006; 17(2):97-106.
47. de Krijger RR, van Nederveen FH, Korpershoek E, Dinjens WNM. New developments in the detection of the clinical behavior of pheochromocytomas and paragangliomas. Endocr Pathol 2006; 17(2):137-141.
48. Tischler AS. Molecular and cellular biology of pheochromocytomas and extra-adrenal paragangliomas. Endocr Pathol 2006;17(4):321-328.
49. Miyake H, Maeda H, Tashiro M, et al. CT of adrenal tumors: frequency and clinical significance of low-attenuation lesions. AJR Am J Roentgenol 1989;152(5):1005-1007.
50. Brink I, Hoegerle S, Klisch J, Bley TA. Imaging of pheochromocytoma and paraganglioma. Fam Cancer 2005;4(1):61-68.
51. Newhouse JH, Heffess CS, Wagner BJ, Imray TJ, Adair CF, Davidson AJ. Large degenerated adrenal adenomas: radiologic-pathologic correlation. Radiology 1999;210(2):385-391.
52. Colby GW, Banks KP, Torres E. AJR teaching file: incidental adrenal mass and hypertension. AJR Am J Roentgenol 2006;187(3 suppl):S470-S472.
53. Jacques AET, Sahdev A, Sandrasagara M, et al. Adrenal phaeochromocytoma: correlation of MRI appearances with histology and function. Eur Radiol 2008;18(12):2885-2892.
54. Varghese JC, Hahn PF, Papanicolaou N, Mayo-Smith WW, Gaa JA, Lee MJ. MR differentiation of phaeochromocytoma from other adrenal lesions based on qualitative analysis of T2 relaxation times. Clin Radiol 1997;52(8):603-606.
55. Blake MA, Kalra MK, Maher MM, et al. Pheochromocytoma: an imaging chameleon. RadioGraphics 2004;24(suppl 1):S87-S99.
56. Shapiro B, Copp JE, Sisson JC, Eyre PL, Wallis J, Beierwaltes WH. Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med 1985; 26(6):576-585.
57. Shulkin BL, Thompson NW, Shapiro B, Francis IR, Sisson JC. Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET. Radiology 1999;212(1):35-41.
58. Timmers HJ, Chen CC, Carrasquillo JA, et al. Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 2009;94(12):4757-4767.
59. Timmers HJ, Kozupa A, Chen CC, et al. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. J Clin Oncol 2007;25(16):2262-2269.
60. Ilias I, Chen CC, Carrasquillo JA, et al. Comparison of 6-18F-fluorodopamine PET with 123I-metaiodobenzylguanidine and 111in-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma. J Nucl Med 2008;49(10):1613-1619.
61. Kawashima A, Sandler CM, Fishman EK, et al. Spectrum of CT findings in nonmalignant disease of the adrenal gland. RadioGraphics 1998;18(2):393-412.
62. Garcia M, Louis LB 4th, Vernon S. Cystic adrenal lymphangioma. Arch Pathol Lab Med 2004; 128(6):713-714.
63. Inokuchi T, Takiuchi H, Moriwaki Y, et al. Retroperitoneal ancient schwannoma presenting as an adrenal incidentaloma: CT and MR findings. Magn Reson Imaging 2006;24(10):1389-1393.
64. Guo YK, Yang ZG, Li Y, et al. Uncommon adrenal masses: CT and MRI features with histopathologic correlation. Eur J Radiol 2007;62(3): 359-370.
65. Maweja S, Materne R, Detrembleur N, et al. Adrenal ganglioneuroma. Am J Surg 2007;194(5): 683-684.
66. Radin R, David CL, Goldfarb H, Francis IR. Adrenal and extra-adrenal retroperitoneal ganglioneuroma: imaging findings in 13 adults. Radiology 1997;202(3):703-707.
67. El-Daly H, Rao P, Palazzo F, Gudi M. A rare entity of an unusual site: adenomatoid tumour of the adrenal gland: a case report and review of the literature. Pathol Res Int 2010;2010(2):702472.
68. Garg K, Lee P, Ro JY, Qu Z, Troncoso P, Ayala AG. Adenomatoid tumor of the adrenal gland: a clinicopathologic study of 3 cases. Ann Diagn Pathol 2005;9(1):11-15.
69. Liu YQ, Zhang HX, Wang GL, Ma LL, Huang Y. A giant cystic adenomatoid tumor of the adrenal gland: a case report. Chin Med J (Engl) 2010;123 (3):372-374.
70. Wong DD, Spagnolo DV, Bisceglia M, Havlat M, McCallum D, Platten MA. Oncocytic adrenocortical neoplasms: a clinicopathologic study of 13 new cases emphasizing the importance of their recognition. Hum Pathol 2011;42(4):489-499.
71. Tahar GT, Nejib KN, Sadok SS, Rachid LM. Adrenocortical oncocytoma: a case report and review of literature. J Pediatr Surg 2008;43(5): E1-E3.
72. Juliano JJ, Cody RL, Suh JH. Metastatic adrenocortical oncocytoma: a case report. Urol Oncol 2008;26(2):198-201.
73. Bisceglia M, Ludovico O, Di Mattia A, et al. Adrenocortical oncocytic tumors: report of 10 cases and review of the literature. Int J Surg Pathol 2004;12(3):231-243.
74. Kumar N, Singh S, Govil S. Adrenal histoplasmosis: clinical presentation and imaging features in nine cases. Abdom Imaging 2003;28(5):703-708.
75. Pulakhandam U, Dincsoy HP. Cytomegaloviral adrenalitis and adrenal insufficiency in AIDS. Am J Clin Pathol 1990;93(5):651-656.
76. Freda PU, Wardlaw SL, Brudney K, Goland RS. Primary adrenal insufficiency in patients with the acquired immunodeficiency syndrome: a report of five cases. J Clin Endocrinol Metab 1994;79 (6): 1540-1545.
77. Allolio B, Fassnacht M. Clinical review: adrenocortical carcinoma-clinical update. J Clin Endocrinol Metab 2006;91(6):2027-2037.
78. Wooten MD, King DK. Adrenal cortical carcinoma: epidemiology and treatment with mitotane and a review of the literature. Cancer 1993;72 (11):3145-3155.
79. Soon PS, McDonald KL, Robinson BG, Sidhu SB. Molecular markers and the pathogenesis of adrenocortical cancer. Oncologist 2008;13 (5):548-561.
80. Venkatesh S, Hickey RC, Sellin RV, Fernandez JF, Samaan NA. Adrenal cortical carcinoma. Cancer 1989;64(3):765-769.
81. King DR, Lack EE. Adrenal cortical carcinoma: a clinical and pathologic study of 49 cases. Cancer 1979;44(1):239-244.
82. Lau SK, Weiss LM. The Weiss system for evaluating adrenocortical neoplasms: 25 years later. Hum Pathol 2009;40(6):757-768.
83. Hamper UM, Fishman EK, Hartman DS, Roberts JL, Sanders RC. Primary adrenocortical carcinoma: sonographic evaluation with clinical and pathologic correlation in 26 patients. AJR Am J Roentgenol 1987;148(5):915-919.
84. Bharwani N, Rockall AG, Sahdev A, et al. Adrenocortical carcinoma: the range of appearances on CT and MRI. AJR Am J Roentgenol 2011;196(6): W706-W714.
85. Boland GW, Lee MJ, Gazelle GS, Halpern EF, McNicholas MM, Mueller PR. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 1998;171(1):201-204.
86. Fishman EK, Deutch BM, Hartman DS, Goldman SM, Zerhouni EA, Siegelman SS. Primary adrenocortical carcinoma: CT evaluation with clinical correlation. AJR Am J Roentgenol 1987; 148(3):531-535.
87. Ferrozzi F, Bova D. CT and MR demonstration of fat within an adrenal cortical carcinoma. Abdom Imaging 1995;20(3):272-274.
88. Soler R, Rodríguez E, López MF, Marini M. MR imaging in inferior vena cava thrombosis. Eur J Radiol 1995;19(2):101-107.
89. Groussin L, Bonardel G, Silvéra S, et al. 18F-fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients. J Clin Endocrinol Metab 2009;94(5):1713-1722.
90. Hussain S, Belldegrun A, Seltzer SE, Richie JP, Gittes RF, Abrams HL. Differentiation of malignant from benign adrenal masses: predictive indices on computed tomography. AJR Am J Roentgenol 1985;144(1):61-65.
91. Musante F, Derchi LE, Zappasodi F, et al. Myelolipoma of the adrenal gland: sonographic and CT features. AJR Am J Roentgenol 1988;151 (5):961-964.
92. Abiven G, Coste J, Groussin L, et al. Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. J Clin Endocrinol Metab 2006;91(7):2650-2655.
93. Leite NP, Kased N, Hanna RF, et al. Cross-sectional imaging of extranodal involvement in abdominopelvic lymphoproliferative malignancies. RadioGraphics 2007;27(6):1613-1634.
94. Rosenberg SA, Diamond HD, Jaslowitz B, Craver LF. Lymphosarcoma: a review of 1269 cases. Medicine (Baltimore) 1961;40:31-84.
95. Anis M, Irshad A. Imaging of abdominal lymphoma. Radiol Clin North Am 2008;46(2): 265-285.
96. Vicks BS, Perusek M, Johnson J, Tio F. Primary adrenal lymphoma: CT and sonographic appearances. J Clin Ultrasound 1987;15(2):135-139.
97. Rashidi A, Fisher SI. Primary adrenal lymphoma: a systematic review. Ann Hematol 2013;92(12): 1583-1593.
98. Hussain HK, Korobkin M. MR imaging of the adrenal glands. Magn Reson Imaging Clin N Am 2004;12(3):515-544.
99. Sohaib SA, Reznek RH. Adrenal imaging. BJU Int 2000;86(suppl 1):95-110.
100. Zhou L, Peng W, Wang C, Liu X, Shen Y, Zhou K. Primary adrenal lymphoma: radiological, pathological, clinical correlation. Eur J Radiol 2012;81 (3):401-405.
101. Paes FM, Kalkanis DG, Sideras PA, Serafini AN. FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease. RadioGraphics 2010;30(1):269-291.
102. Ilias I, Sahdev A, Reznek RH, Grossman AB, Pacak K. The optimal imaging of adrenal tumours: a comparison of different methods. Endocr Relat Cancer 2007;14(3):587-599.
103. Lee CW, Tsang YM, Liu KL. Primary adrenal leiomyosarcoma. Abdom Imaging 2006;31(1): 123-124.
104. Boland GW, Blake MA, Hahn PF, Mayo-Smith WW. Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization. Radiology 2008;249(3):756-775.
105. Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer 1950;3(1):74-85.
106. Chong S, Lee KS, Kim HY, et al. Integrated PET-CT for the characterization of adrenal gland lesions in cancer patients: diagnostic efficacy and interpretation pitfalls. RadioGraphics 2006;26(6): 1811-1824; discussion 1824-1826.